Document:ICH ICH E2F Guideline 2010: Difference between revisions
From GxPlex
Gxplex admin (talk | contribs) m 1 revision imported |
Migrate to Template:DocumentData for PageForms (GxPlexBot) |
||
| Line 1: | Line 1: | ||
{{DocumentData | |||
|reference=ICH ICH E2F Guideline 2010 | |reference=ICH ICH E2F Guideline 2010 | ||
|validity_area=ICH | |validity_area=ICH | ||
Revision as of 12:54, 16 July 2026
| Document information | |
|---|---|
| Reference | ICH ICH E2F Guideline 2010 |
| Validity area | ICH |
| Scope(s) | G |
| Document name | ICH E2F Guideline |
| Version / Revision | 2010 |
| Status | Current |
| Document type | International guideline |
| Language(s) | EN |
| Description | DEVELOPMENT SAFETY UPDATE REPORT |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
References
| Scope | Document part | Language | Preview | |
|---|---|---|---|---|
| ICH ICH E2F Guideline 2010 1 | G | 1 | EN | The Development Safety Update Report (DSUR) proposed in this guideline is intended to be a common standard for periodic reporting on drugs under devel… |
References
| Reference | Scope | Document part | Language | Preview |
|---|---|---|---|---|
| Reference:ICH ICH E2F Guideline 2010 1 | G | 1 | EN | The Development Safety Update Report (DSUR) proposed in this guideline is intended to be a common standard for periodic reporting on drugs under development (including marketed drugs that are under ... |
